BR112021018496A2 - Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica - Google Patents
Cápsulas e revestimento de cápsula para formas de dosagem de residência gástricaInfo
- Publication number
- BR112021018496A2 BR112021018496A2 BR112021018496A BR112021018496A BR112021018496A2 BR 112021018496 A2 BR112021018496 A2 BR 112021018496A2 BR 112021018496 A BR112021018496 A BR 112021018496A BR 112021018496 A BR112021018496 A BR 112021018496A BR 112021018496 A2 BR112021018496 A2 BR 112021018496A2
- Authority
- BR
- Brazil
- Prior art keywords
- gastric residence
- dosage forms
- capsules
- capsule
- capsule coating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962821352P | 2019-03-20 | 2019-03-20 | |
| PCT/US2020/023704 WO2020191229A1 (en) | 2019-03-20 | 2020-03-19 | Capsules and capsule coatings for gastric residence dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021018496A2 true BR112021018496A2 (pt) | 2021-11-30 |
Family
ID=72519175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021018496A BR112021018496A2 (pt) | 2019-03-20 | 2020-03-19 | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12447130B2 (https=) |
| EP (1) | EP3941445A4 (https=) |
| JP (2) | JP2022525926A (https=) |
| CN (2) | CN119033720A (https=) |
| AU (1) | AU2020240108B2 (https=) |
| BR (1) | BR112021018496A2 (https=) |
| CA (1) | CA3134049A1 (https=) |
| IL (1) | IL286512B2 (https=) |
| MX (2) | MX2021011314A (https=) |
| WO (1) | WO2020191229A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| BR112021018496A2 (pt) | 2019-03-20 | 2021-11-30 | Lyndra Therapeutics Inc | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica |
| AU2020242062B2 (en) | 2019-03-20 | 2025-12-11 | Nortiva Bio, Inc. | Coatings for gastric residence dosage forms |
| JP7847119B2 (ja) | 2020-07-29 | 2026-04-16 | ザ・セカント・グループ・エルエルシー | 架橋ポリ（セバシン酸グリセロール）を含む構造を含む形状誘導型制御放出および保持 |
| CN120091832A (zh) * | 2022-08-03 | 2025-06-03 | 林德拉治疗公司 | 用于胃驻留系统的金属芯部 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706149D0 (en) | 1997-03-25 | 1997-05-14 | Scherer Corp R P | Comestible capsules having flavoured coatings |
| WO2003051304A2 (en) | 2001-12-15 | 2003-06-26 | Spherics, Inc. | Bioadhesive drug delivery system with enhanced gastric retention |
| DK1578350T3 (da) | 2002-03-26 | 2009-08-10 | Euro Celtique Sa | Sammensætninger med gel-coating med depotvirkning |
| IL166183A0 (en) * | 2005-01-06 | 2006-01-15 | Yissum Res Dev Co | Novel diagnostic and imaging techniques of the gi tract |
| KR20080005429A (ko) | 2005-04-19 | 2008-01-11 | 알자 코포레이션 | 트라마돌 및 가바펜틴을 포함하는 물질의 배합물 |
| WO2007002518A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Delayed release or extended-delayed release dosage forms of pramipexole |
| JP4948828B2 (ja) | 2005-11-28 | 2012-06-06 | 森下仁丹株式会社 | 胃内浮遊滞留シームレスカプセルとその製造方法 |
| CA2675230A1 (en) | 2006-01-10 | 2008-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| EP2997953B1 (en) | 2006-01-18 | 2018-12-26 | Intec Pharma Ltd. | Delivery device for oral intake of an agent |
| WO2007093999A1 (en) | 2006-02-15 | 2007-08-23 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
| JP2012500230A (ja) | 2008-08-18 | 2012-01-05 | 北京天衡▲薬▼物研究院 | 胃内滞留薬物放出システム及びその製造方法と使用 |
| US8006033B2 (en) | 2008-09-09 | 2011-08-23 | Intel Corporation | Systems, methods, and apparatuses for in-band data mask bit transmission |
| CA2745741A1 (en) | 2008-12-04 | 2010-06-10 | Intec Pharma Ltd. | Zaleplon gastroretentive drug delivery system |
| US20100286628A1 (en) * | 2009-05-07 | 2010-11-11 | Rainbow Medical Ltd | Gastric anchor |
| US8414559B2 (en) * | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
| EP2490677A2 (en) * | 2009-10-19 | 2012-08-29 | Intec Pharma Ltd. | Novel gastroretentive dosage forms of poorly soluble drugs |
| CA2825917C (en) | 2011-02-14 | 2016-08-30 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
| WO2014035639A1 (en) | 2012-08-29 | 2014-03-06 | Cardiac Pacemakers, Inc. | Enhanced low friction coating for medical leads and methods of making |
| WO2015187746A1 (en) | 2014-06-02 | 2015-12-10 | Teva Pharmaceutical Industries Ltd. | Expandable gastroretentive dosage form |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| NZ727659A (en) | 2014-06-11 | 2021-12-24 | Massachusetts Inst Technology | Residence structures and related methods |
| WO2015195989A1 (en) | 2014-06-20 | 2015-12-23 | Banner Life Sciences Llc | Enteric soft capsule compositions |
| EP3288604B1 (en) | 2015-05-01 | 2021-11-17 | Massachusetts Institute of Technology | Triggerable shape memory induction devices |
| MX387092B (es) | 2015-06-17 | 2025-03-19 | Biogen Ma Inc | Particulas de dimetilfumarato y composiciones farmaceuticas de estas. |
| US20190000768A1 (en) | 2015-08-04 | 2019-01-03 | Fuji Capsule Co., Ltd. | Enteric capsule |
| US11576859B2 (en) | 2015-10-23 | 2023-02-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| WO2017100367A1 (en) | 2015-12-08 | 2017-06-15 | Lyndra, Inc. | Geometric configurations for gastric residence systems |
| CN109310639A (zh) | 2016-05-27 | 2019-02-05 | 林德拉有限公司 | 用于胃驻留系统的材料结构 |
| JP2019532947A (ja) | 2016-09-30 | 2019-11-14 | リンドラ，インコーポレイティド | アダマンタン系薬物の持続的送達のための胃内滞留システム |
| CN110035718B (zh) * | 2016-12-02 | 2021-04-06 | 克雷西奥生物科技有限公司 | 胃内滞留系统 |
| CA3066658A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
| US11793751B2 (en) | 2017-09-20 | 2023-10-24 | Lyndra Therapeutics, Inc. | Encapsulation of gastric residence systems |
| CN111587088A (zh) * | 2017-11-28 | 2020-08-25 | 麻省理工学院 | 胃驻留电子装置 |
| JP2021535090A (ja) | 2018-08-15 | 2021-12-16 | リンドラ セラピューティクス， インコーポレイティド | 治療薬物の腸内送達のためのシステム |
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| AU2020242062B2 (en) | 2019-03-20 | 2025-12-11 | Nortiva Bio, Inc. | Coatings for gastric residence dosage forms |
| BR112021018496A2 (pt) | 2019-03-20 | 2021-11-30 | Lyndra Therapeutics Inc | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica |
| MX2022005494A (es) | 2019-11-08 | 2022-08-11 | Lyndra Therapeutics Inc | Sistemas de residencia gastrica para la administracion de agentes activos. |
| JP2022553867A (ja) | 2019-11-08 | 2022-12-26 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留を改善するフィラメントを有する胃内滞留システム |
| IL292848A (en) | 2019-11-08 | 2022-07-01 | Lyndra Therapeutics Inc | Polymeric linkers for a gastric residence system |
| US20220387312A1 (en) | 2019-11-08 | 2022-12-08 | Lyndra Therapeutics, Inc. | Gastric residence systems having arms with controlled stiffness for improved gastric residence |
| WO2021092486A1 (en) | 2019-11-08 | 2021-05-14 | Lyndra, Inc. | Formulations for release-rate modulating films for gastric residence systems |
| US20240390270A1 (en) | 2021-01-19 | 2024-11-28 | Lyndra Therapeutics, Inc. | Gastric residence systems for administration of risperidone |
| JP2024517829A (ja) | 2021-05-05 | 2024-04-23 | リンドラ セラピューティクス， インコーポレイティド | メタドンを含む胃内滞留システム |
| WO2022236288A1 (en) | 2021-05-05 | 2022-11-10 | Lyndra Therapeutics, Inc. | Gastric residence systems comprising buprenorphine and naloxone |
| AU2023209872A1 (en) | 2022-01-19 | 2024-08-01 | Nortiva Bio, Inc. | Dosage forms for gastric retention |
| CN120091832A (zh) | 2022-08-03 | 2025-06-03 | 林德拉治疗公司 | 用于胃驻留系统的金属芯部 |
| JP2025531626A (ja) | 2022-09-30 | 2025-09-22 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留システムを用いたリスペリドンの投与レジメン |
| US20240398701A1 (en) | 2023-06-02 | 2024-12-05 | Lyndra Therapeutics, Inc. | Manufacturing methods for gastric residence systems |
-
2020
- 2020-03-19 BR BR112021018496A patent/BR112021018496A2/pt unknown
- 2020-03-19 US US17/593,436 patent/US12447130B2/en active Active
- 2020-03-19 CN CN202411107403.6A patent/CN119033720A/zh active Pending
- 2020-03-19 IL IL286512A patent/IL286512B2/en unknown
- 2020-03-19 MX MX2021011314A patent/MX2021011314A/es unknown
- 2020-03-19 WO PCT/US2020/023704 patent/WO2020191229A1/en not_active Ceased
- 2020-03-19 CA CA3134049A patent/CA3134049A1/en active Pending
- 2020-03-19 JP JP2021556484A patent/JP2022525926A/ja active Pending
- 2020-03-19 AU AU2020240108A patent/AU2020240108B2/en active Active
- 2020-03-19 EP EP20774505.0A patent/EP3941445A4/en active Pending
- 2020-03-19 CN CN202080034334.4A patent/CN113966216A/zh active Pending
-
2021
- 2021-09-17 MX MX2025012985A patent/MX2025012985A/es unknown
-
2025
- 2025-01-16 JP JP2025005892A patent/JP2025066761A/ja active Pending
- 2025-07-08 US US19/262,609 patent/US20250332111A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3134049A1 (en) | 2020-09-24 |
| CN119033720A (zh) | 2024-11-29 |
| IL286512B1 (en) | 2025-11-01 |
| JP2022525926A (ja) | 2022-05-20 |
| EP3941445A1 (en) | 2022-01-26 |
| IL286512B2 (en) | 2026-03-01 |
| US20250332111A1 (en) | 2025-10-30 |
| AU2020240108B2 (en) | 2025-12-04 |
| MX2021011314A (es) | 2021-12-10 |
| EP3941445A4 (en) | 2023-08-02 |
| WO2020191229A1 (en) | 2020-09-24 |
| US12447130B2 (en) | 2025-10-21 |
| IL286512A (en) | 2021-10-31 |
| CN113966216A (zh) | 2022-01-21 |
| AU2020240108A1 (en) | 2021-11-11 |
| US20220160642A1 (en) | 2022-05-26 |
| MX2025012985A (es) | 2025-12-01 |
| JP2025066761A (ja) | 2025-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021018496A2 (pt) | Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica | |
| BR112017001032A2 (pt) | revestimento para cateter expansível intraluminal que fornece transferência de contato de micro-reservatórios de fármacos | |
| BR112021018424A2 (pt) | Revestimentos para formas de dosagem de residência gástrica | |
| CY1121301T1 (el) | Πολλαπλης φασης καψουλες μαλακης πηκτης, συσκευη και μεθοδος αυτων | |
| BR112019012071A2 (pt) | tratamento de uma doença do trato gastrointestinal com um inibidor de integrina | |
| BR112015004771A2 (pt) | métodos, sistemas, e dispositivos de estojo retraível | |
| BR112018003845A2 (pt) | auxiliares cirúrgicos com medicamentos afetados por materiais ativadores | |
| BR112016028643A2 (pt) | ?dispositivo de vedação e sistema de entrega? | |
| BR112017014607A2 (pt) | dispositivo híbrido para correção cirúrgica da aorta e método de uso do mesmo | |
| BR112013028453B8 (pt) | Uso de uma composição de revestimento, formas de dosagem farmacêuticas ou nutracêuticas gastrorresistentes, e composição do polímero do núcleo/invólucro | |
| EP3411024A4 (en) | ORAL PHARMACEUTICAL FORM OF LOXAPIN WITH FILM | |
| BR112022003895A2 (pt) | Sistema e método de entrega de múltiplos fármacos | |
| BR112013003762A2 (pt) | invólucro de comprimido para aprimorar o desempenho | |
| BR112012028868A2 (pt) | formas de dosagem para cineol | |
| BR112015020307A2 (pt) | formulação de cápsula rígida | |
| BR112017022856A2 (pt) | combinação de dose fixa inviolável que proporciona rápida liberação de duas drogas a partir de partículas | |
| CY1122232T1 (el) | Ενωση ιμιδαζοδιαζεπινης | |
| BR112017000468A2 (pt) | forma de dosagem de cápsula de liberação prolongada | |
| UY39783A (es) | Dispositivo de cápsula con una abertura formada por la superposición de dos envolturas de media cáps | |
| CY1125503T1 (el) | Διαδικασια για στερεα σκευασματα μεσαλαζινης | |
| BR112018068910A2 (pt) | sultiame para o tratamento de apneia do sono | |
| BR112018069440A2 (pt) | forma de dosagem oral | |
| Sonawane et al. | An Innovative Approach | |
| WO2018193337A3 (en) | POLYMER-BASED FORMULATION FOR THE RELEASE OF MEDICINES AND BIOACTIVE PRODUCTS AT SPECIFIC GIT SITES | |
| HUE060300T2 (hu) | Totarol alkalmazása és totarolt tartalmazó gyógyászati készítmény |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |